Pendarvis David
- SEC CIK
- 0001196723
In the past year, 2 open-market purchase filings worth $207.5K and no sales.
Current role at each company
- WDFC WD 40 CoDirectoras of Feb 6, 2026
- RMD Resmed IncChief Administrative Officeras of Jun 30, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $207.5K
- 2 filings
- Sold
- –
- 0 filings
- Net
- +$207.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Pendarvis David as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
WDFC WD 40 Co
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 12, 2024 (view filing) | Apr 12 | Same day | Pendarvis DavidDirector | PPurchase | +328 | $234.75 | +$77.0K | +7.1%4.93K after | |
| Oct 30, 2025 (view filing) | Oct 30 | Same day | Pendarvis DavidDirector | PPurchase | +523 | $196.37 | +$102.7K | +9.8%5.86K after | |
| Feb 6, 2026 (view filing) | Feb 5 | 1 day | Pendarvis DavidDirector | PPurchase | +424 | $247.15 | +$104.8K | +6.5%6.90K after |
RMD Resmed Inc
Chief Administrative Officer24 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2021 (view filing) | Jul 6 | 1 day | Pendarvis DavidChief Administrative Officer | SSaleResMed Common Stock | −1.49K | $247.12 | −$367.5K | −1.2%124.9K after | |
| Aug 4, 2021 (view filing) | Aug 3 | 1 day | Pendarvis DavidChief Administrative Officer | SSaleResMed Common Stock | −1.49K | $269.38 | −$400.6K | −1.2%123.4K after | |
| Sep 7, 2021 (view filing) | Sep 3 | 4 days | Pendarvis DavidChief Administrative Officer | SSaleResMed Common Stock | −1.49K | $292.16 | −$434.4K | −1.2%124.0K after | |
| Oct 5, 2021 (view filing) | Oct 4 | 1 day | Pendarvis DavidChief Administrative Officer | SSaleResMed Common Stock | −1.49K | $260.79 | −$387.8K | −1.2%122.5K after | |
| Nov 5, 2021 (view filing) | Nov 3 | 2 days | Pendarvis DavidChief Administrative Officer | SSaleResMed Common Stock | −1.49K | $264.29 | −$392.5K | −1.2%121.0K after | |
| Dec 6, 2021 (view filing) | Dec 3 | 3 days | Pendarvis DavidChief Administrative Officer | SSaleResMed Common Stock | −1.54K | $257.93 | −$398.2K | −1.3%117.6K after | |
| Jan 4, 2022 (view filing) | Jan 3 | 1 day | Pendarvis DavidChief Administration Officer | SSaleResMed Common Stock | −1.54K | $258.52 | −$399.2K | −1.3%116.0K after | |
| Feb 4, 2022 (view filing) | Feb 3 | 1 day | Pendarvis DavidChief Administration Officer | SSaleResMed Common Stock | −1.54K | $232.87 | −$359.6K | −1.3%114.5K after | |
| Mar 4, 2022 (view filing) | Mar 3 | 1 day | Pendarvis DavidChief Administrative Officer | SSaleResMed Common Stock | −1.54K | $250.62 | −$387.0K | −1.3%112.9K after | |
| Apr 5, 2022 (view filing) | Apr 4 | 1 day | Pendarvis DavidChief Administrative Officer | SSaleResMed Common Stock | −1.54K | $246.60 | −$380.8K | −1.4%111.4K after |